Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 25, Issue 11, 2015, Pages 1016-1024

  Kiage, J N ^a,f   Sampson, U K A ^b   Lipworth, L ^a   Fazio, S ^c   Mensah, G A ^b   Yu, Q ^d   Munro, H ^e   Akwo, E A ^a   Dai, Q ^a   Blot, W J ^a,e   Kabagambe, E K ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d WESTAT   (United States)

^e INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cardiovascular disease; Fish; Hypertension; Mortality; Prospective; PUFA

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MONOUNSATURATED FATTY ACID; N3 POLYUNSATURATED FATTY ACID; N6 POLYUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; UNCLASSIFIED DRUG; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; EDUCATIONAL STATUS; ETHNICITY; FAT INTAKE; FEMALE; FISH INTAKE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; PROTEIN INTAKE; RISK FACTOR; SMOKING; ANIMAL; BLOOD; BLOOD PRESSURE; CALORIC INTAKE; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; DIET; DRUG EFFECTS; FISH; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SEA FOOD; SOCIOECONOMICS;

ADULT; ANIMALS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIET; ENERGY INTAKE; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FISHES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEAFOOD; SOCIOECONOMIC FACTORS;

EID: 84960497686     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.07.006     Document Type: Article

References (42)

1. Burr M.L., Fehily A.M., Gilbert J.F., Rogers S., Holliday R.M., Sweetnam P.M., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2:757-761.
2. Marchioli R., Barzi F., Bomba E., Chieffo C., Di G.D., Di M.R., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897-1903.
3. Miura K., Stamler J., Nakagawa H., Elliott P., Ueshima H., Chan Q., et al. Relationship of dietary linoleic acid to blood pressure. The international study of macro-micronutrients and blood pressure study [corrected]. Hypertension 2008, 52:408-414.
4. Wang L., Manson J.E., Forman J.P., Gaziano J.M., Buring J.E., Sesso H.D. Dietary fatty acids and the risk of hypertension in middle-aged and older women. Hypertension 2010, 56:598-604.
5. Kromhout D., Giltay E.J., Geleijnse J.M. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010, 363:2015-2026.
6. Bosch J., Gerstein H.C., Dagenais G.R., Diaz R., Dyal L., Jung H., et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012, 367:309-318.
7. Roncaglioni M.C., Tombesi M., Avanzini F., Barlera S., Caimi V., Longoni P., et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 2013, 368:1800-1808.
8. Fulcher J., O'Connell R., Voysey M., Emberson J., Blackwell L., Mihaylova B., et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 2015, 385:1397-1405.
9. Lipworth L., Fazio S., Kabagambe E.K., Munro H.M., Nwazue V.C.T.R.E., McLaughlin J.K., et al. A prospective study of statin use and mortality among 67,385 blacks and whites in the Southeastern United States. Clin Epidemiol 2013, 6:15-25.
10. de Lorgeril M., Salen P., Defaye P., Rabaeus M. Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?. BMC Med 2013, 11:5.
11. Bjorck L., Welin C., Rosengren A. Secular trends in lipid-lowering treatment and lipid levels after a first acute myocardial infarction. Vasc Health Risk Manag 2007, 3:1045-1051.
12. Mann D., Reynolds K., Smith D., Muntner P. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother 2008, 42:1208-1215.
13. Barzi F., Woodward M., Marfisi R.M., Tavazzi L., Valagussa F., Marchioli R. Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr 2003, 57:604-611.
14. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009, 373:1175-1182.
15. Ludman A., Venugopal V., Yellon D.M., Hausenloy D.J. Statins and cardioprotection - more than just lipid lowering?. Pharmacol Ther 2009, 122:30-43.
16. Juncos L.I., Juncos L.A., Garcia N.H. The antihypertensive actions of statins: modulation by salt intake. Am J Hypertens 2012, 25:1140-1148.
17. Strazzullo P., Kerry S.M., Barbato A., Versiero M., D'Elia L., Cappuccio F.P. Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials. Hypertension 2007, 49:792-798.
18. Golomb B.A., Dimsdale J.E., White H.L., Ritchie J.B., Criqui M.H. Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med 2008, 168:721-727.
19. Signorello L.B., Hargreaves M.K., Blot W.J. The Southern Community Cohort Study: investigating health disparities. J Health Care Poor Underserved 2010, 21:26-37.
20. Sampson U.K.A., Edwards T.L., Jahangir E., Munro H., Wariboko M., Wassef M.G., et al. Factors associated with the prevalence of hypertension in the Southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study. Circ Cardiovasc Qual Outcomes 2014, 7:33-54.
21. Signorello L.B., Munro H.M., Buchowski M.S., Schlundt D.G., Cohen S.S., Hargreaves M.K., et al. Estimating nutrient intake from a food frequency questionnaire: incorporating the elements of race and geographic region. Am J Epidemiol 2009, 170:104-111.
22. Lipworth L., Okafor H., Mumma M.T., Edwards T.L., Roden D.M., Blot W.J., et al. Race-specific impact of atrial fibrillation risk factors in blacks and whites in the Southern Community Cohort Study. Am J Cardiol 2012, 110:1637-1642.
23. Willett W.C., Howe G.R., Kushi L.H. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997, 65:1220S-1228S.
24. Kiage J.N., Merrill P.D., Robinson C.J., Cao Y., Malik T.A., Hundley B.C., et al. Intake of trans fat and all-cause mortality in the reasons for geographical and racial differences in stroke (REGARDS) cohort. Am J Clin Nutr 2013, 97:1121-1128.
25. Bonaa K.H., Bjerve K.S., Straume B., Gram I.T., Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N Engl J Med 1990, 322:795-801.
26. Appel L.J., Miller E.R., Seidler A.J., Whelton P.K. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993, 153:1429-1438.
27. Grimsgaard S., Bonaa K.H., Jacobsen B.K., Bjerve K.S. Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension 1999, 34:478-483.
28. Xun P., Hou N., Daviglus M., Liu K., Morris J.S., Shikany J.M., et al. Fish oil, selenium and mercury in relation to incidence of hypertension: a 20-year follow-up study. J Intern Med 2011, 270:175-186.
29. Livingstone K.M., Givens D.I., Cockcroft J.R., Pickering J.E., Lovegrove J.A. Is fatty acid intake a predictor of arterial stiffness and blood pressure in men? Evidence from the Caerphilly prospective study. Nutr Metab Cardiovasc Dis 2013, 23:1079-1085.
30. Kabagambe E.K., Tsai M.Y., Hopkins P.N., Ordovas J.M., Peacock J.M., Borecki I.B., et al. Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin Chem 2008, 54:154-162.
31. Correa V., Gus M., Fuchs F.D. Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects?. Expert Rev Cardiovasc Ther 2010, 8:775-779.
32. Kenny D., Warltier D.C., Pleuss J.A., Hoffmann R.G., Goodfriend T.L., Egan B.M. Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol 1992, 70:1347-1352.
33. Chin J.P., Gust A.P., Nestel P.J., Dart A.M. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993, 21:22-28.
34. Harris W.S., Rambjor G.S., Windsor S.L., Diederich D. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 1997, 65:459-464.
35. Nestel P., Shige H., Pomeroy S., Cehun M., Abbey M., Raederstorff D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 2002, 76:326-330.
36. Dangardt F., Osika W., Chen Y., Nilsson U., Gan L.M., Gronowitz E., et al. Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents. Atherosclerosis 2010, 212:580-585.
37. Ramel A., Martinez J.A., Kiely M., Bandarra N.M., Thorsdottir I. Moderate consumption of fatty fish reduces diastolic blood pressure in overweight and obese European young adults during energy restriction. Nutrition 2010, 26:168-174.
38. He K., Liu K., Daviglus M.L., Mayer-Davis E., Jenny N.S., Jiang R., et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am J Clin Nutr 2008, 88:1111-1118.
39. Mozaffarian D., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C. Trans fatty acids and cardiovascular disease. N Engl J Med 2006, 354:1601-1613.
40. Kiage J.N., Merrill P.D., Judd S.E., He K., Lipworth L., Cushman M., et al. Intake of trans fat and incidence of stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. Am J Clin Nutr 2014, 99:1071-1076.
41. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
42. Cutler J.A., Sorlie P.D., Wolz M., Thom T., Fields L.E., Roccella E.J. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008, 52:818-827.